Literature DB >> 32312609

Full Spectrum of Cancer Patients in SARS-CoV-2 Infection Still Being Described.

X Liang1, C Yang2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32312609      PMCID: PMC7136880          DOI: 10.1016/j.clon.2020.03.016

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
Madam — Liang and colleagues [1] first reported a nationwide analysis with cancer patients in SARS-CoV-2 infection in China. However, there are some aspects worth reinterpreting that may cause misleading conclusions. First, the proportion of COVID-19 patients with cancer in this cohort was not equal to the incidence of cancer in all COVID-19 cases. Moreover, detection signal bias may exist in cancer patients, as they may pay more attention to their health condition and are more likely to seek medical help in the early stages of any disease, which may increase the detection rate in cancer patients. Most importantly, age is a very important confounding factor. The mean age of cancer patients (63.1 years) was significantly higher than that of those without cancer (48.7 years). Moreover, when focused on the 18 cases with cancer, the mean age with severe events was even higher than in those without severe events (71.89 years versus 54.33 years). There is clear evidence from other studies that older patients are more likely to be infected and have more serious conditions and death [2,3]. More male patients (male 12 versus female 6) in cancer cohorts may also response for the high proportion of severe events in cancer patients, as female patients might have relatively mild symptoms. The logistic regression analysis further shows that age and gender have a significant impact on severity, thus it is necessary to carry out age stratification analysis or paired analysis according to age and gender. The results should be reported after adjusting for these two factors. Collectively, there were several confounding factors and defects in the statistical methods of this paper, and the effectiveness of the results may be uncertain. More rigid designed studies are needed to depict the full spectrum of cancer patients in SARS-CoV-2 infection.

Conflicts of Interest

The authors declare no conflict of interest.
  3 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

3.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

Authors:  Wenhua Liang; Weijie Guan; Ruchong Chen; Wei Wang; Jianfu Li; Ke Xu; Caichen Li; Qing Ai; Weixiang Lu; Hengrui Liang; Shiyue Li; Jianxing He
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316

  3 in total
  2 in total

1.  Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19.

Authors:  N Joseph; A Choudhury
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-04-30       Impact factor: 4.126

Review 2.  A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives.

Authors:  Vinod K Ramani; Radheshyam Naik
Journal:  Health Sci Rep       Date:  2021-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.